15 July 2014 A study published today in Clinical Cancer Research demonstrates that tamoxifen applied to the skin in a gel form was as effective as oral tamoxifen in decreasing breast cancer cell growth and was associated with fewer side effects in patients with ductal carcinoma in-situ (DCIS). Dr. Seema Kahn and colleagues randomized 27 women diagnosed with DCIS to receive either…